Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010
Neoplastic Meningitis
Neurologist 12:179-187, Chamberlain,M.C., 2006
Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004
Neurotoxocity of Intrathecal Methotrexate: MR Imaging Findings
AJNR 24:1887-1890, Sandoval,C.,et al, 2003
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Clinical Outcome in Aggressively Treated Meningeal Carcinomatosis
Arch Neurol 51:457-461, Grant,R.,et al, 1994
Treatment of Leptomeningeal Metastasis with Intravent Admin of Depot Cytarabine (DTC 101)
Arch Neurol 50:261-264, Chamberlain,M.C.,et al, 1993
Clinical Outcome in Aggressively Treated Meningeal Gliomatosis
Neurol 42:252-254, Grant,R.,et al, 1992
Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991
Stroke-Like Syndrome, Mineralizing Microangiopathy, and Neuroaxonal Dyst with Intrathecal Methotrexate
Neurol 41:1847-1848, Phanthumchinda,K.,et al, 1991
Central Nervous System Metastases from Non-Hodgkin's Lymphoma:Treatment & Prophylaxis
Am J Med 84:425-435, Recht,L.,et al, 1988
Paraplegia and Quadriplegia after Intrathecal Chemotherapy
Arch Phys Med Rehabil 69:1054-1056, Werner,R.A., 1988
Ommaya Reservoirs in 387 Cancer Patients:A 15-Year Experiment
Neurol 35:1274-1278, Obbens,E.A.M.,et al, 1985
CT Abnormalities & Altered Methotrexate Clearance in Children with CNS Leukemia
Neurol 34:229-233, Duffner,P.K.,et al, 1984
Transient Neurologic Dysfunction Following Moderate-Dose Methotrexate for Undifferentiated Lymphoma
Cancer 54:2003-2005, Martino,R.L.,et al, 1984
Clin Path. Conference
Necrotizing Encephalomyelopath, Secondary to Irradiation & Intrathecal Methotrexate, Case Record 36-, 983, 311:653-662,1984., 1984
Treatment of Massive Intrathecal Methotrexate Overdose by Ventriculolumbar Perfusion
NEJM 311:386-388, Spiegel,R.J.,et al, 1984
Seizures in Childhood Lymphoblastic Leukaemia Patients
Lancet 2:1422-1424, Ochs,J.J.,et al, 1984
Paraparesis Following Intrathecal Chemotherapy
Neurol 33:1032-1038, Hahn,A.F.,et al, 1983
Intraventricular Methotrexate Therapy of Leptomeningeal Metastasis from Breast Carcinoma
Neurol 33:1565-1572, OngerboerdeVisser,B.W.,et al, 1983
Focal Encephalopathy Following Methotrexate Therapy
Arch Neurol 38:450-452, Packer,R.J.,et al, 1981
Effects of Prophyl. Treat. of CNS on Intellect. Funct. of Children with Acute lymph. Leuk
Am J Med 71:47-52, Moss,H.A., 1981
Fatal Myeloencephalopathy Caused by Intrathecal Vincristine
Neurol 30:867-871, Slyter,H.,et al, 1980
Long-term Neurological Implications of Somnolence Syndrome in Children with Acute Lymphocyte Leukemia
Ann Neurol 8:273-277, Ch'ien,L.T.,et al, 1980
Cerebral Reticulum Cell Sarcoma
Arch Neurol 36:727, DeCoul,A.A.W.,et al, 1979
Transient Cerebral Dysfunction Following Chemotherapy for Osteogenic Sarcoma
Ann Neurol 3:441, Allen,J.C.,et al, 1978
Abnor CT Scans of Brain in Asympt. Chil with Acute Lymph. Leuk. after Prophy. Treat of CNS with Radia & Intrathe Chemo
NEJM 298:815, Peylan-Ramu,N.,et al, 1978
Intrathecal Methotrexate Causing Paraplegia in a Middle-Aged Woman
Acta Haemat 60:59-60, Weiss,S.,et al, 1978
Encephalomyelopathy Following Intrathecal Methotrexate Treatment in a Child with Acute Leukemia
Cancer 41:1211-1215, Skullerud,D.,et al, 1978
Leukoencephalopathy in Childhood Leukemia
et al. , Neurol 27:609977., Devivo,D.C., 1977
Germinoma of third Ventricle (Case Record of MGH)
NEJM 293:653, Locke,S.,et al, 1975
Methotrexate Dist. in CSF after IV, Ventricular & Lumbar Inject
NEJM 293:161, Shapiro,W.R.,et al, 1975
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
A 66-Year-Old Woman With Progressive Encephalopathy and Bilateral Hearing Loss
Neurol 100:254-258, Rivers,D.,et al, 2023
New-Onset Diplopia and Headache in a Patient with Metastatic Breast Cancer
Neurol 100:927-931, Rizzo,S.A.,et al, 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
Clinicopathologic Conference, Plasm-Cell Myeloma Post-Transplant Lymphoproliferative Disorder
NEJM 386:2508-2516, Case 20-2022, 2022
Imaging Findings in Children Presenting with CNS Nelarabine Toxicity
AJNR 43:1802-1809, Serrallach,B.L.,et al, 2022
Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions
Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021
A 59-Year-Old Woman Presenting with Diplopia, Dysarthria, Right-sided Weakness, and Encephalopathy
Neurol 97:e859-e864, Manzano, G.S.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021